Assessing β-amyloid-induced NLRP3 inflammasome activation in primary microglia

Methods in Molecular Biology

Volumn 1040, Issue , 2013, Pages 1-8

  Schnaars, Mareike ^a   Beckert, Hannes ^a   Halle, Annett ^a  

^a CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

A ; Fibrillar; Inflammasome; Oligomeric; Primary microglial cells; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; INFLAMMASOME; INTERLEUKIN 1BETA;

AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE COURSE; MICROGLIA; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 84880491311     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-523-1_1     Document Type: Article

References (10)

1. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft G, LaDu MJ (2002) Oligomeric and fi brillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277(35):32046-32053. doi: 10.1074/jbc. M201750200
2. Tomic JL, Pensalfi ni A, Head E, Glabe CG (2009) Soluble fi brillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis 35(3):352-358. doi: 10.1016/j. nbd.2009.05.024
3. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fl uid phase macropinocytosis. J Neurosci 29(13):4252-4262. doi: 10.1523/JNEUROSCI.5572-08.2009, doi:29/13/4252 [pii]
4. Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE, Kohsaka S, Jucker M, Calhoun ME (2008) Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28(16):4283-4292. doi: 10.1523/JNEUROSCI.4814-07.2008, doi:28/16/4283 [pii]
5. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49(4):489-502. doi: 10.1016/j.neuron.2006.01.022, doi:S0896-6273(06)00075-4 [pii]
6. Griffi n WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86(19):7611-7615
7. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fl uid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202(1-2):17-20
8. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 infl ammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857-865
9. Fa M, Orozco IJ, Francis YI, Saeed F, Gong Y, Arancio O (2010) Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. J Vis Exp (41), e1884, doi:10.3791/1884. 2010
10. Jan A, Hartley DM, Lashuel H (2010) Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat Protoc 5(6):1186-1209